-
Keros Therapeutics (NASDAQ:KROS) Downgraded by Cantor Fitzgerald to Neutral
Source: Buzz FX / 21 Jan 2025 07:31:17 America/Chicago
Keros Therapeutics (NASDAQ:KROS) Downgraded by Cantor Fitzgerald to Neutral Written by MarketBeat January 21, 2025 Share Link copied to clipboard. Keros Therapeutics ( NASDAQ:KROS - Get Free Report ) was downgraded by Cantor Fitzgerald from
Read more...